Primitive hematopoietic stem cells show a polyclonal pattern in myelodysplastic syndromes

Haematologica

Volumn 89, Issue 1, 2004, Pages 21-28

  Guidetti, Francesca ^a   Grazioli, Sandra ^a   Capelli, Francesca ^a   Marini, Claudia ^a   Gallicchio, Margherita ^b   De Micheli, Daniela ^b   Castello, Luigi ^a   Sainaghi, Pier Paolo ^a   Fra, Gian Paolo ^a   Saglio, Giuseppe ^b   Avanzi, Gian Carlo ^a,c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Amedeo Avogadro University   (Italy)

Author keywords

Clonality; HUMARA; LTC IC; Myelodysplastic syndromes

Indexed keywords

DNA;

AGED; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CLONAL VARIATION; CYTOGENETICS; DNA SEQUENCE; FEMALE; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; X CHROMOSOME INACTIVATION;

AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CHROMOSOMES, HUMAN, X; CLONE CELLS; DNA METHYLATION; DOSAGE COMPENSATION, GENETIC; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; PHENOTYPE; PLURIPOTENT STEM CELLS; STEM CELLS;

EID: 0842328530     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Ann Oncol 1999;10:1419-32.
2. Prchal JT, Throckmorton DW, Carroll AJ, Fyson EW, Gams RA, Prchal JF. A common progenitor for human myeloid and lymphoid cells. Nature 1978;274:590-1.
3. Abrahamson G, Boultwood H, Madden J, Kelly S, Oscier DG, Rack K, et al. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. Br J Haematol 1991;79:550-5.
4. Amenomori T, Tomonaga M, Yoshida Y, Kuriyama K, Matsuo T, Jinnai I, et al. Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvenile chronic myeloid leukaemia. Both granulocyte-macrophage precursors and erythroid precursors carry identical marker chromosome. Br J Haematol 1986;64:539-46.
5. Raskind WH, Tirumali N, Jacobson R, Singer J, Fialkow PJ. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984;63:1318-23.
6. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridation: lineage, response to growth factor therapy and clone expansion. Blood 1993;81:1580-5.
7. Gerritsen WR, Donohue J, Bauman J, Jhanwar SC, Kernan NA, Castro-Malaspina H, et al. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage but not in the lymphoid lineage as detected by fluorescent in situ hybridation. Blood 1992;80:217-24.
8. Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989;73:248-54.
9. Tefferi A, Thibodeau SN, Solberg LA. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990;75:1770-3.
10. Van Kamp H, Fibbe WE, Jansen RP, van der Keur M, de Graaff E, Willemze R, et al. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood 1992;80:1774-80.
11. Van Lom K, Hagemeijer A, Vendekerckhove F, Smit EM, Lowenberg B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol 1996;93:594-600.
12. Anan K, Ito M, Misawa M, Ohe Y, Kai S, Kohsaki M, et al. Clonal analysis of peripheral blood and hemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen receptor (HUMARA) gene. Br J Haematol 1995;89:838-44.
13. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 1991;88:6848-52.
14. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992;51:1229-39.
15. Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, et al. Clonality in juvenile chronic myelogenous leukemia. Blood 1995;85:21-30.
16. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, et al. Langerhans's-cell histiocytosis (Histiocytosis X)-a clonal proliferative disease. N Engl J Med 1994;331:154-60.
17. Tsukamoto N, Morita K, Maehara T, Okamoto K, Karasawa M, Omine M, et al. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993;83:589-94.
18. Asano H, Ohashi H, Ichihara M, Kinoshita T, Murate T, Kobayashi M, et al. Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 1994;84:588-94.
19. Delforge M, Demuynck H, Vandenberghe P, Verhoef G, Zachee P, van Duppen V, et al. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high risk myelodysplastic syndromes. Blood 1995;86:3660-7.
20. Vadhan-Raj S, Broxmeyer H, Spitzer G, LeMaistre A, Hultman S, Ventura G, et al. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood 1989;74:1491-8.
21. Ganser A, Janssen JW, Ottman OG, Seipelt G, Eder M, Becher R, et al. In vivo effects of granulocyte-macrophage colony-stimulating factor interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders. Leukemia 1991;5:487-92.
22. Ito T, Ohashi H, Kagami Y, Ichikawa A, Saito H, Hotta T. Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia 1994;8:839-43.
23. Carella AM, Dejana A, Lerma E, Podesta M, Benvenuto F, Chimirri F, et al. In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia. Br J Haematol 1996;95:127-30.
24. Petzer AL, Hogge DE, Landsdorp PM, Reid DS, Eaves CJ. Self renewal of primitive human hematopoietic cells (long-term-culture-initiating-cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996;93:1470-4.
25. Avanzi GC, Gallicchio M, Cavalloni G, Gammaitoni L, Leone F, Rosina A, et al. GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. Exp Hematol 1997;25:1219-26.
26. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985;227:642-5.
27. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996;88:59-65.
28. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA. Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 1992;8:346-52.
29. Delforge M, Demuynck H, Verhoef G, Vandenberghe P, Zachee P, Maertens J, et al. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal hemopoiesis in complete haematclogical remission. Br J Haematol 1998;102:486-94.
30. Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D, et al. Involvement and functional impairment of the CD34+CD38-Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002;100:259-67.
31. Asimakopoulos FA, Holloway TL, Nacheva EP, Scott MA, Fenaux P, Green AR. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood 1996;87:1561-70.
32. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483-9.
33. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995;91:403-8.
34. Samuelsson J, Larfars G. Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor. Leuk Res 1999;23:513-7.
35. Gowans D, O'Sullivan A, Rollinson S, Roddam P, Groves M, Fegan C, et al. Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. Br J Haematol 2002;117:541-5.
36. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002;43:2083-92.
37. Loughran TP. Clonal diseases of large granular lymphocytes. Blood 1993;821-14.
38. Masuko-Hongo K, Kato T, Suzuki S, Sekine T, Kurokawa M, Ueda S, et al. Frequent clonal expansion of peripheral T cells in patients with autoimmune diseases: a novel detecting system possibly applicable to laboratory examination. J Clin Lab Anal 1998;12:162-7.
39. Plasilova M, Risitano A, Maciejewski JP. Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases. Hematology 2003;8:173-81.
40. Gale RE, Wheadon H, Boulos P, Linch DC. Tissue specificy of X-chromosome inactivation patterns. Blood 1994;83:2899-905.
41. Champion K, Gilbert J, Asimakopoulos F, Hinshelwood S, Green AR. Clonal hemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol 1997;97:920-6.
42. Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R, et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 2000;96:2012-21.
43. Jaju RJ, Jones M, Boultwood J, Kelly S, Mason DY, Wainscoat JS, et al. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q-syndrome. Genes Chromosomes Cancer 2000;29:276-80.
44. Sato T, Kim S, Selleri C, Young NS, Maciejewski JP. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 1998;12:1187-94.
45. Flores-Figueroa E, Gutierrez-Espindola G, Guerrero-Rivera S, Pizzuto-Chavez J, Mayani H. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation. Leuk Res 1999;23:385-94.
46. Grossi A, Musto P, Santini V, Balestri F, Fabbri A, Falcone A, Sanpaolo G. Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromes. Haematologica 2002;87:322-3.
47. Leone G, Teofili L, Voso MT, Lubbert M. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica 2002;87:1324-41.
48. Alessandrino EP, Amadori S, Barosi G, Cazzola M, Grossi A, Liberato LN, et al. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. Haematologica 2002;87:1286-306.